Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siglitazar sodium tablets in type 2 diabetes mellitus
CTR20131996Phase 3Completed
- Sponsor
- Akeso, Inc.
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of chiglitazar in type 2 diabetes mellitus (T2DM), sponsored by Akeso, Inc.. Started May 2014; status: completed.
02
Drugs
chiglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20131996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131996.